Human Papilloma Virus Infection: Clinical Trials

32 trials for Human Papilloma Virus Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 3 unknown, 2 active not recruiting, 1 not yet recruiting. 12 Not applicable, 7 Phase 2, 2 Phase 1, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 8, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 27Completed 5, Active not recruiting 1, Withdrawn 1
Phase 12Completed 1, Terminated 1
Phase 32Completed 1, Withdrawn 1
Phase 41Unknown 1

Follow Human Papilloma Virus Infection: new trials by email Literature Review of Human Papilloma Virus Infection trials Research Report on Human Papilloma Virus Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Understanding Women's Values in Managing Human Papillomavirus (HPV)
No intervention - Human Papilloma Virus Infection
CompletedUniversity of Aberdeen92023-11-062026-08-31
Immunogenicity of 9-valent HPV Vaccine
9-valent HPV vaccine - Human Papilloma Virus Infection
Phase 4UnknownTalia Sainz Costa1202023-03-072024-03-08
Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection
Chinese medicine and Lactobacillus, Chinese medicine, Lactobacillus - Human Papilloma Virus Infection
Not applicableUnknownPeking University People's Hospital2402023-03-012024-06-21
Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
diagnostic cervical conization - Human Papilloma Virus Infection, Human Papilloma Virus Integration
Not applicableNot yet recruitingTongji Hospital2502022-10-012022-09-08
Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)
HPV Diagnostic Kit (Bio Farma) - Human Papilloma Virus Infection
Not applicableCompletedPT Bio Farma9002022-04-012023-11-01
Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic
probiotic, placebo - Human Papilloma Virus Infection
Phase 2 / Phase 3WithdrawnUniversiti Sains Malaysia2021-12-272024-05-10
Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance
PAPILOCARE - Squamous Intraepithelial Lesions of the Cervix, Human Papilloma Virus Infection
Not applicableCompletedCentre Hospitalier Régional d'Orléans812020-11-172023-06-15
A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli), Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae) - Human Papilloma Virus Infection
Phase 2CompletedBeijing Health Guard Biotechnology, Inc7802020-05-232023-01-23
Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples
First-void urine collection, Blood draw - Human Papilloma Virus Infection
CompletedUniversiteit Antwerpen502020-05-112021-09-29
Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium
HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong), Bio-Plex® 200 system (Bio- Rad, Hercules, CA) - Human Papilloma Virus Infection, Pterygium
CompletedChulalongkorn University1412020-01-012020-07-14
Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.
Papilocare vaginal gel - Human Papilloma Virus, Human Papilloma Virus Infection
Not applicableCompletedProcare Health Iberia S.L.1642019-09-252026-09-02
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Topical ABI-1968 cream - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection
Phase 1TerminatedAntiva Biosciences62018-12-172019-07-24
Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine
First-void urine collection, Blood draw - Human Papilloma Virus Infection
CompletedUniversiteit Antwerpen632017-12-112022-11-08
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
ABI-1968 - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection
Phase 1CompletedAntiva Biosciences572017-08-112019-02-07
The HPV Self-test as a Test of Cure in Madagascar
HPV test - Human Papilloma Virus Infection, Cervical Intraepithelial Neoplasia Grade 2/3
Not applicableCompletedUniversity Hospital, Geneva1172016-06-012016-10-17
Community-Driven Cervical Cancer Prevention in Western Kenya
Community-based testing with standard linkage to care, Community-based HPV testing with enhanced linkage to care - Human Papilloma Virus Infection, Carcinoma in Situ of Uterine Cervix
Not applicableCompletedDuke University72002016-01-012019-04-10
Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV
Papilocare vaginal gel - Human Papilloma Virus Infection, Human Papilloma Virus
Not applicableCompletedProcare Health Iberia S.L.1342015-10-192021-02-16
Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)
First-void urine collection, Blood draw - Human Papilloma Virus Infection
CompletedUniversiteit Antwerpen572015-09-012017-06-15
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
imiquimod, fluorouracil, infrared photocoagulation therapy - Anal Cancer, High-grade Squamous Intraepithelial Lesion
Phase 3CompletedAIDS Malignancy Consortium44462014-09-242024-07-26
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
paclitaxel albumin-stabilized nanoparticle formulation, carboplatin, radiation therapy - Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx
Phase 2CompletedUniversity of Chicago622014-09-222024-09-24

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Papillomavirus Infections (32)  ·  Uterine Cervical Neoplasms (7)  ·  Anus Neoplasms (5)  ·  HIV Infections (4)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Squamous Intraepithelial Lesions (3)  ·  Uterine Cervical Dysplasia (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Condylomata Acuminata (1)  ·  DNA Virus Infections (1)  ·  Oropharyngeal Neoplasms (1)  ·  Pterygium (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Skin Diseases, Viral (1)

Broader conditions

Communicable Diseases (32)  ·  Disease Attributes (32)  ·  Genital Diseases (32)  ·  Infections (32)  ·  Pathologic Processes (32)  ·  Pathological Conditions, Signs and Symptoms (32)  ·  Sexually Transmitted Diseases (32)  ·  Sexually Transmitted Diseases, Viral (32)  ·  Urogenital Diseases (32)  ·  DNA Virus Infections (31)  ·  Tumor Virus Infections (31)  ·  Virus Diseases (31)  ·  Neoplasms (16)  ·  Neoplasms by Site (14)  ·  Female Urogenital Diseases (9)

Interventions

Blood Specimen Collection (3)  ·  Carboplatin (3)  ·  Cisplatin (2)  ·  Fluorouracil (2)  ·  Paclitaxel (2)  ·  Radiotherapy, Intensity-Modulated (2)  ·  Taxes (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Colposcopy (1)  ·  Early Intervention, Educational (1)  ·  Human Papillomavirus DNA Tests (1)  ·  Hydroxyurea (1)  ·  Imiquimod (1)  ·  Lacteol (1)

Sponsors

Universiteit Antwerpen (3)  ·  AIDS Malignancy Consortium (2)  ·  Antiva Biosciences (2)  ·  National Cancer Institute (NCI) (2)  ·  Procare Health Iberia S.L. (2)  ·  Barretos Cancer Hospital (1)  ·  Beijing Health Guard Biotechnology, Inc (1)  ·  Centre Hospitalier Régional d'Orléans (1)  ·  Chulalongkorn University (1)  ·  Duke University (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Gen-Probe, Incorporated (1)  ·  Hologic Deutschland GmbH (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (12)  ·  Belgium (3)  ·  China (3)  ·  Spain (3)  ·  Australia (2)  ·  Puerto Rico (2)  ·  Brazil (1)  ·  France (1)  ·  Indonesia (1)  ·  Kenya (1)  ·  Madagascar (1)  ·  Malaysia (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Pierre Van Damme, Prof, MD, PhD (2)  ·  Adhemar Longatto-Filho, PhD (1)  ·  Adriana T Lorenzi, MSc (1)  ·  Allen Chen (1)  ·  Beth Glenn, PhD (1)  ·  Binti Sany Salina, Doctor (1)  ·  Bor-Ching Sheu, MD,PhD (1)  ·  Cornelia Trimble (1)  ·  Electra Paskett (1)  ·  Elizabeth Chiao (1)  ·  Everett Vokes, MD (1)  ·  Francisco Garcia (1)  ·  Ilse De Coster, MD (1)

Results publications

PMID 18630456, PMID 24388920, PMID 26019212, PMID 28434660, PMID 29197067, PMID 29207966, PMID 29801496, PMID 29970063, PMID 30355760, PMID 30481287, PMID 31129514, PMID 31345973, PMID 33109637, PMID 33594934, PMID 33743523, PMID 34699271, PMID 35416975, PMID 35704479, PMID 35714277, PMID 36424257, PMID 40313865, PMID 40360161, PMID 40493877, PMID 40495681, PMID 40884128, PMID 41322412

NIH funding

U01CA121947 (2), 2016 (1), N01CN35158 (1), P30CA014599 (1), P30CA016042 (1), P30CA023074 (1), R01CA163103 (1), U10CA021115 (1), U10CA027469 (1), U10CA180820 (1), UM1CA121947 (1)